Grivox

Grivox is an over‑the‑counter oral mucosal antiseptic that combines amylmetacresol and 2,4‑dichlorobenzyl alcohol. It is formulated for direct use in the mouth and throat to provide antimicrobial action. The product is marketed in the European Union and is classified under ATC code R02AB02 as a throat antiseptic. Each dose delivers a measured amount of both agents, designed to reduce bacterial and viral presence on the oropharyngeal mucosa without requiring a prescription.

Grivox is indicated for the symptomatic relief of mild to moderate throat discomfort and for reducing microbial load in the oral cavity.

- Relief of sore throat associated with viral or bacterial upper respiratory infections. - Management of minor mouth and throat infections such as pharyngitis or tonsillitis. - Adjunctive use during cold or flu season to help control oral microbial proliferation. - Supportive care for individuals who experience irritation after dental procedures or prolonged voice use.

Side effects reported with Grivox are generally mild and transient, reflecting its local action in the mouth and throat.

Common: - Temporary burning or tingling sensation in the mouth. - Mild taste alteration or after‑taste. - Slight irritation of the oral mucosa.

Serious: - Allergic reaction presenting as rash, swelling, or difficulty breathing. - Persistent ulceration or severe inflammation of the throat. - Unexplained fever or systemic signs following use.

When using Grivox, certain precautions help ensure safe and effective use.

- Do not swallow large quantities; use only as directed for oral rinse or lozenge. - Avoid use in individuals with known hypersensitivity to amylmetacresol, 2,4‑dichlorobenzyl alcohol, or related compounds. - Keep out of reach of children; accidental ingestion may cause irritation. - If symptoms persist beyond 48 hours, discontinue and seek medical advice. - Do not use concurrently with other oral antiseptic products to prevent excessive irritation.

Grivox may interact with other substances applied to the oral cavity or systemic medications that affect mucosal integrity.

Avoid: - Concurrent use of other antiseptic mouthwashes containing alcohol or chlorhexidine, which can increase mucosal irritation. - Use with topical anesthetics that may mask adverse reactions.

Use with caution: - Patients taking anticoagulant therapy, as oral irritation could theoretically increase bleeding risk. - Individuals on immunosuppressive drugs, because infection control is critical. - Use with other over‑the‑counter cough or throat lozenges containing similar active ingredients to avoid duplication of effect.